Patient outcomes and socioeconomic health factors
In recent years, the United States has seen a shift in greater awareness of the importance of SDOH and toward a more comprehensive approach to healthcare.
Social determinants of health (SDOH) are defined by the World Health Organization (WHO) as the conditions in which people are born, grow, live, work and age. New evidence shows that they can be as important in patient outcomes as genetics, especially in cancer treatment.
According to new research by Cardinal Health Specialty Solutions, SDOH significantly impacts outcomes for cancer patients. The study is part of an ongoing series of reports designed to help physicians, manufacturers and other healthcare stakeholders understand the trends and changes within specialty medicine and patient care.
For more information and updates on these findings, read the full article from Medical Economics.
Exogenous hormones and patients at increased risk for breast cancer
October 17th 2023This lecture, presented by Holly J. Pederson, MD, at The Menopause Society 2023 Annual Meeting, looked at combined oral contraceptives in BRCA carriers and other high-risk patients, and hormone therapy in postmenopausal gene carriers as well as other high-risk women.
Read More
Hormone replacement therapy does not increase breast cancer recurrence, mortality in survivors
July 20th 2022An analysis of data from more than 8400 postmenopausal women with a history of early-stage nonmetastatic, ER-positive breast cancer suggests there was no increase in risk of breast cancer recurrence or mortality observed with use of vaginal estrogen therapy or menopausal hormone therapy.
Read More
